Primary toxicological evaluation of nitroxoline on laboratory animals.
DOI:
https://doi.org/10.26641/2307-0404.2017.1.101440Keywords:
Nitroxoline, parameters of toxicity, skin-resorptive effect, locally irritating effect, cumulative activityAbstract
Nitroxoline is an effective antibacterial agent that is industrially produced by chemical and pharmaceutical enterprises in Ukraine. Parameters of its toxicity are determined under conditions of acute and subchronic toxicological experiments on 3 kinds of laboratory animals, by administering the drug orally and by application onto the skin and mucous membranes. The duration of acute experiment was 14 days, subchronical - 24 days. It was found that median lethal dose (DL50) for white female rats is 980 (852:1127) mg/kg, of white male rats – 835 mg/kg, white male mice– 660 mg/kg, by this parameter the drug can be attributed to 3 class of hazard – moderately hazardous substance. Average effective time of death (ET50) for albino rats is 28 hours. Species sensitivity of laboratory animals to nitroxoline is slightly expressed. The death of the animals starts on the first day after the injection and is recorded during three days of the experiment. In application on intact skin, locally-irritant and skin-resorptive effects are absent. After contact with the mucous membrane of the eye the drug causes weak irritant effect. Nitroxoline has a moderate cumulative activity.References
[Guidelines for the formulation of research to substantiate the health standards of harmful substances in the working area: Method. directions N 2163-80]. Moskva, 1980;20. Russian.
[Rationale for the maximum permissible concentration of drugs in the air of the working area in the ambient air of places: Method. instructions N 544, 2005]. Kyiv, MOZ Ukrainsky, Kyiv, 2015;19. Ukrainian.
[Assessment of the impact of hazardous chemicals on the skin and justification of maximum permissible levels of skin contamination: ME 2102-79].Moscow, 1980;23. Russian.
Lim RK, Rink KG, Glass HG, Soaje-Echague EA. A method for the evaluation of cumulation and tolerance by the determination of acute and subchronic median effective doses. Arch. Intern. Pharm. 1961;130:336−52.
Bergogne-Berezin E1, Berthelot G, Muller-Serieys C. Present status of nitroxoline. Pathol Biol (Paris). 1987;35:873.
Maida A, Chrusаiеlska K. Medicine Pracy. 1965;XXX1V:321-96.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2017 Medical Perspectives
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Submitting manuscript to the journal "Medicni perspektivi" the author(s) agree with transferring copyright from the author(s) to publisher (including photos, figures, tables, etc.) editor, reproducing materials of the manuscript in the journal, Internet, translation into other languages, export and import of the issue with the author’s article, spreading without limitation of their period of validity both on the territory of Ukraine and other countries. This and other mutual duties of the author and all co-authors separately and editorial board are secured by written agreement by special form to use the article, the sample of which is presented on the site.
Author signs a written agreement and sends it to Editorial Board simultaneously with submission of the manuscript.